They demonstrated that vaccination against GPNMB in the male premature ageing model mice extended their lifespan by 5.4 weeks, mainly eliminated the Gpnmb-positive senescent cells, and attenuated age-related pathologies such as atherosclerosis and metabolic abnormalities [14]. This evidence concerns the gene GPNMB and atherosclerosis.